# BMP4

## Overview
Bone morphogenetic protein 4 (BMP4) is a gene that encodes a protein belonging to the transforming growth factor-beta (TGF-beta) superfamily, which is involved in a wide array of biological processes. The BMP4 protein is a multifunctional growth factor that plays a pivotal role in embryonic development, cellular differentiation, and tissue homeostasis. It is particularly influential in the formation of bone and cartilage, as well as in non-osteogenic processes such as neural induction and somite development (Chen2004Bone). BMP4 functions primarily as a dimer, either as a homodimer or in combination with other BMPs, such as BMP7, to exert its biological effects (Leong1996Bone; Carreira2014Bone). The protein's activity is modulated through interactions with various receptors and antagonists, which finely tune its signaling pathways to ensure proper developmental outcomes (ten1994Identification; Zimmerman1996The). Mutations in the BMP4 gene have been linked to several developmental disorders and diseases, highlighting its critical role in human health and disease (Yu2019BMP4; Bakrania2008Mutations).

## Structure
Bone morphogenetic protein 4 (BMP4) is a member of the TGF-beta superfamily and is synthesized as a large precursor molecule. The primary structure of BMP4 consists of a polypeptide chain with approximately 120 amino acids, including seven conserved cysteine residues. Six of these cysteines form a cysteine knot motif, which is stabilized by three intramolecular disulfide bonds, while the seventh cysteine is involved in dimer stabilization through an intermolecular cystine bridge (Leong1996Bone; Carreira2014Bone).

The secondary structure of BMP4 includes alpha-helices and beta-sheets, contributing to its three-dimensional conformation. The tertiary structure is characterized by the cystine knot, which forms the core of the monomer, and four strands of antiparallel beta-sheet emanating from the knot (Granjeiro2005Bone). 

In terms of quaternary structure, BMP4 functions as a dimer, which can be either a homodimer or a heterodimer, notably with BMP7. These dimers are crucial for its biological activity, with heterodimers often exhibiting greater osteoinductive activity than homodimers (Leong1996Bone; Carreira2014Bone).

Post-translational modifications of BMP4 include glycosylation, which enhances the stability and half-life of the protein and influences receptor coupling specificity (Carreira2014Bone). The protein is also subject to proteolytic cleavage at a consensus Arg-X-X-Arg site to generate the mature, active form (Granjeiro2005Bone).

## Function
BMP4 (bone morphogenetic protein 4) is a multifunctional growth factor that plays a significant role in various biological processes, particularly in embryonic development and cellular differentiation. It is a member of the TGF-beta superfamily and is involved in the induction of cartilage and bone formation, as well as in non-osteogenic developmental processes such as neural induction and somite development (Chen2004Bone). BMP4 signals through type I receptors, specifically ALK-3 and ALK-6, which are crucial for transducing intracellular signals that lead to its biological effects (ten1994Identification).

In the context of chondrogenesis, BMP4 acts as an instructive factor that induces mesenchymal cells to differentiate into chondrocytes, promoting cartilage maturation and formation. It enhances the expression of cartilage-specific genes such as Col2a1 and Sox9, contributing to the development of cartilaginous structures (Hatakeyama2004Distinct). BMP4 also plays a role in the differentiation of human embryonic stem cells into trophoblast cells, which are essential for placental development. This process involves the expression of trophoblast markers and the production of placental hormones (Amita2013Complete).

## Clinical Significance
Mutations in the BMP4 gene are associated with a range of developmental anomalies and diseases. In the eye, BMP4 mutations can lead to conditions such as anophthalmia, microphthalmia, retinal dystrophy, and coloboma, often due to its role in lens induction and optic cup formation (Reis2011BMP4; Bakrania2008Mutations). BMP4 haploinsufficiency is linked to anterior segment dysgenesis and elevated intraocular pressure, which are associated with glaucoma (Chang2001Haploinsufficient). 

In the context of colorectal cancer, germline mutations in BMP4 have been identified, suggesting a role in tumorigenesis. Specific mutations such as p.R286X, p.W325C, and p.C373S have been found in patients with early-onset colorectal cancer or a family history of the disease (Lubbe2010Evaluation).

BMP4 is also implicated in skeletal and digit anomalies, including polydactyly and syndactyly, due to its involvement in digit separation during development (Bakrania2008Mutations). Additionally, BMP4 mutations have been associated with dental anomalies like tooth agenesis and low bone mass, potentially due to impaired BMP4 function affecting the Smad signaling pathway (Yu2019BMP4). 

These findings underscore the critical role of BMP4 in various developmental processes and its potential involvement in multiple congenital and acquired conditions.

## Interactions
BMP4 interacts with a variety of proteins that modulate its signaling pathways. Biglycan (Bgn) binds directly to BMP4, forming a complex that affects BMP4 signaling. High concentrations of Biglycan inhibit BMP4 activity, such as the induction of alkaline phosphatase in C2C12 cells. Biglycan also enhances the binding of Chordin to BMP4, increasing Chordin's antagonistic effects on BMP4 signaling (Moreno2005Biglycan).

Noggin is another protein that binds BMP4 with high affinity, effectively inhibiting its activity by preventing BMP4 from interacting with its receptors. This interaction is crucial for noggin's role in the Spemann organizer function, which involves blocking BMP signaling (Zimmerman1996The).

Agrin, through its N-terminal region, binds BMP4 and inhibits its activity in luciferase reporter assays. This binding suggests that Agrin can act as an inhibitor of BMP4 by potentially preventing its association with cellular receptors (Bányai2010Agrin).

Wise, a secreted protein, also interacts with BMP4. It inhibits BMP4 signaling by binding to BMP ligands, although this inhibition is affected by the presence of additional LRP6, indicating a preference for binding LRP6 over BMP4 (Lintern2009Characterization).


## References


[1. (Reis2011BMP4) Linda M. Reis, Rebecca C. Tyler, Kala F. Schilter, Omar Abdul-Rahman, Jeffrey W. Innis, Beth A. Kozel, Adele S. Schneider, Tanya M. Bardakjian, Edward J. Lose, Donna M. Martin, Ulrich Broeckel, and Elena V. Semina. Bmp4 loss-of-function mutations in developmental eye disorders including short syndrome. Human Genetics, 130(4):495–504, February 2011. URL: http://dx.doi.org/10.1007/s00439-011-0968-y, doi:10.1007/s00439-011-0968-y. This article has 84 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-011-0968-y)

[2. (Lintern2009Characterization) Katherine B. Lintern, Sonia Guidato, Alison Rowe, José W. Saldanha, and Nobue Itasaki. Characterization of wise protein and its molecular mechanism to interact with both wnt and bmp signals. Journal of Biological Chemistry, 284(34):23159–23168, August 2009. URL: http://dx.doi.org/10.1074/jbc.M109.025478, doi:10.1074/jbc.m109.025478. This article has 144 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M109.025478)

[3. (Hatakeyama2004Distinct) Yuji Hatakeyama, Rocky S. Tuan, and Lillian Shum. Distinct functions of bmp4 and gdf5 in the regulation of chondrogenesis. Journal of Cellular Biochemistry, 91(6):1204–1217, March 2004. URL: http://dx.doi.org/10.1002/jcb.20019, doi:10.1002/jcb.20019. This article has 128 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.20019)

[4. (Bányai2010Agrin) László Bányai, Peter Sonderegger, and László Patthy. Agrin binds bmp2, bmp4 and tgfβ1. PLoS ONE, 5(5):e10758, May 2010. URL: http://dx.doi.org/10.1371/journal.pone.0010758, doi:10.1371/journal.pone.0010758. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0010758)

[5. (Bakrania2008Mutations) Preeti Bakrania, Maria Efthymiou, Johannes C. Klein, Alison Salt, David J. Bunyan, Alex Wyatt, Chris P. Ponting, Angela Martin, Steven Williams, Victoria Lindley, Joanne Gilmore, Marie Restori, Anthony G. Robson, Magella M. Neveu, Graham E. Holder, J Richard O. Collin, David O. Robinson, Peter Farndon, Heidi Johansen-Berg, Dianne Gerrelli, and Nicola K. Ragge. Mutations in bmp4 cause eye, brain, and digit developmental anomalies: overlap between the bmp4 and hedgehog signaling pathways. The American Journal of Human Genetics, 82(2):304–319, February 2008. URL: http://dx.doi.org/10.1016/j.ajhg.2007.09.023, doi:10.1016/j.ajhg.2007.09.023. This article has 194 citations.](https://doi.org/10.1016/j.ajhg.2007.09.023)

[6. (Moreno2005Biglycan) Mauricio Moreno, Rosana Muñoz, Francisco Aroca, Mariana Labarca, Enrique Brandan, and Juan Larraín. Biglycan is a new extracellular component of the chordin–bmp4 signaling pathway. The EMBO Journal, 24(7):1397–1405, March 2005. URL: http://dx.doi.org/10.1038/sj.emboj.7600615, doi:10.1038/sj.emboj.7600615. This article has 89 citations.](https://doi.org/10.1038/sj.emboj.7600615)

[7. (Lubbe2010Evaluation) Steven J. Lubbe, Alan M. Pittman, Cornelis Matijssen, Philip Twiss, Bianca Olver, Amy Lloyd, Mobshra Qureshi, Nathan Brown, Emma Nye, Gordon Stamp, Julian Blagg, and Richard S. Houlston. Evaluation of germline bmp4 mutation as a cause of colorectal cancer. Human Mutation, 32(1):E1928–E1938, October 2010. URL: http://dx.doi.org/10.1002/humu.21376, doi:10.1002/humu.21376. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21376)

[8. (Granjeiro2005Bone) J.M. Granjeiro, R.C. Oliveira, J.C. Bustos-Valenzuela, M.C. Sogayar, and R. Taga. Bone morphogenetic proteins: from structure to clinical use. Brazilian Journal of Medical and Biological Research, 38(10):1463–1473, October 2005. URL: http://dx.doi.org/10.1590/s0100-879x2005001000003, doi:10.1590/s0100-879x2005001000003. This article has 102 citations and is from a poor quality or predatory journal.](https://doi.org/10.1590/s0100-879x2005001000003)

[9. (ten1994Identification) P. ten Dijke, H. Yamashita, T.K. Sampath, A.H. Reddi, M. Estevez, D.L. Riddle, H. Ichijo, C.H. Heldin, and K. Miyazono. Identification of type i receptors for osteogenic protein-1 and bone morphogenetic protein-4. Journal of Biological Chemistry, 269(25):16985–16988, June 1994. URL: http://dx.doi.org/10.1016/s0021-9258(17)32506-1, doi:10.1016/s0021-9258(17)32506-1. This article has 562 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)32506-1)

[10. (Zimmerman1996The) Lyle B Zimmerman, José M De Jesús-Escobar, and Richard M Harland. The spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell, 86(4):599–606, August 1996. URL: http://dx.doi.org/10.1016/s0092-8674(00)80133-6, doi:10.1016/s0092-8674(00)80133-6. This article has 1292 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0092-8674(00)80133-6)

[11. (Yu2019BMP4) Miao Yu, Hao Wang, Zhuangzhuang Fan, Chencheng Xie, Haochen Liu, Yang Liu, Dong Han, Sing-Wai Wong, and Hailan Feng. Bmp4 mutations in tooth agenesis and low bone mass. Archives of Oral Biology, 103:40–46, July 2019. URL: http://dx.doi.org/10.1016/j.archoralbio.2019.05.012, doi:10.1016/j.archoralbio.2019.05.012. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.archoralbio.2019.05.012)

[12. (Chen2004Bone) Di Chen, Ming Zhao, and Gregory R. Mundy. Bone morphogenetic proteins. Growth Factors, 22(4):233–241, December 2004. URL: http://dx.doi.org/10.1080/08977190412331279890, doi:10.1080/08977190412331279890. This article has 1648 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/08977190412331279890)

[13. (Amita2013Complete) Mitsuyoshi Amita, Katsuyuki Adachi, Andrei P. Alexenko, Sunilima Sinha, Danny J. Schust, Laura C. Schulz, R. Michael Roberts, and Toshihiko Ezashi. Complete and unidirectional conversion of human embryonic stem cells to trophoblast by bmp4. Proceedings of the National Academy of Sciences, March 2013. URL: http://dx.doi.org/10.1073/pnas.1303094110, doi:10.1073/pnas.1303094110. This article has 274 citations.](https://doi.org/10.1073/pnas.1303094110)

[14. (Leong1996Bone) Li Ming Leong and Paul M. Brickell. Bone morphogenetic protein-4. The International Journal of Biochemistry &amp; Cell Biology, 28(12):1293–1296, December 1996. URL: http://dx.doi.org/10.1016/s1357-2725(96)00075-1, doi:10.1016/s1357-2725(96)00075-1. This article has 28 citations.](https://doi.org/10.1016/s1357-2725(96)00075-1)

[15. (Chang2001Haploinsufficient) Bo Chang, Richard S Smith, Maureen Peters, Olga V Savinova, Norman L Hawes, Adriana Zabaleta, Steven Nusinowitz, Janice E Martin, Muriel L Davisson, Constance L Cepko, Brigid LM Hogan, and Simon WM John. Haploinsufficient bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genetics, November 2001. URL: http://dx.doi.org/10.1186/1471-2156-2-18, doi:10.1186/1471-2156-2-18. This article has 108 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2156-2-18)

[16. (Carreira2014Bone) Ana Claudia Carreira, Gutemberg Gomes Alves, William Fernando Zambuzzi, Mari Cleide Sogayar, and José Mauro Granjeiro. Bone morphogenetic proteins: structure, biological function and therapeutic applications. Archives of Biochemistry and Biophysics, 561:64–73, November 2014. URL: http://dx.doi.org/10.1016/j.abb.2014.07.011, doi:10.1016/j.abb.2014.07.011. This article has 141 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.abb.2014.07.011)